BioTime acquires ES Cell International
May 8, 2010 by biotechconnection.com · Leave a Comment
BioTime acquires ES Cell International
BioTime, Inc., a biotechnology company that develops and markets products in the field of human stem cells and regenerative medicine, today announced that it has completed its acquisition of the Singapore company ES Cell International Pte Ltd.
Read more on News-Medical-Net
BIOTECH: Key embryonic stem cell patent rejected
May 8, 2010 by biotechconnection.com · Leave a Comment
BIOTECH: Key embryonic stem cell patent rejected
A key patent on how to grow human embryonic stem cells has beenrejected by a federal agency, the latest twist in a complicated,years-long case.
Read more on North County Times
Researcher Obtains Embryonic Stem Cell Line
May 8, 2010 by biotechconnection.com · Leave a Comment
Researcher Obtains Embryonic Stem Cell Line
OMAHA, Neb. (AP) — A University of Nebraska Medical Center professor has obtained an embryonic stem cell line approved under President Barack Obama’s less restrictive research guidelines.
Read more on Yankton Press & Dakotan
Osiris Therapeutics Receives FDA Orphan Drug Designation For Stem Cell Treatment For Type 1 Diabetes
May 7, 2010 by biotechconnection.com · Leave a Comment
Osiris Therapeutics Receives FDA Orphan Drug Designation For Stem Cell Treatment For Type 1 Diabetes
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to [...]
Wisconsin Faces Set Back in Stem Cell Patent Battle
May 7, 2010 by biotechconnection.com · Leave a Comment
Wisconsin Faces Set Back in Stem Cell Patent Battle
MADISON, Wis. (AP) — An attempt to protect a patent that covers embryonic stem cell research pioneered at the University of Wisconsin-Madison has suffered a defeat.
Read more on WSAW Wausau